FRP Advisory advises Prism on Chame sale

FRP corporate finance has announced it has advised Prism’s management team on a “strategic sale” to Charme Capital Partners, a pan-European mid-market private equity firm.

Headquartered in Wakefield, Prism Healthcare manufactures and supplies a broad range of products and services to health and care providers across the UK, and internationally through a network of distributors.

The company employs more than 650 people across the UK and its portfolio includes safe patient handling, bathing, accessibility, and pressure area care products.

In this latest deal, Charme Capital Partners becomes the business’ majority investor and will be supported by Prism’s existing investor, Limerston Capital.

Prism’s five-strong management team, including CEO Paul Morton, CFO James Hart and executive chairman Stuart Meldrum, were advised by FRP’s corporate finance team, led by director Gary Hyem.

Hyem said: “I’ve worked closely with Prism Healthcare and the management team for over 15 years, and it has been great to support them on such a huge growth journey.

“This tertiary buyout and the investment from Charme Capital Partners are testament to the strength of the team, the business they have built and its position as the largest operator in the UK market, and I’m looking forward to seeing where Prism Healthcare goes next as it continues to drive expansion both at home and overseas.”

Paul Morton, CEO of Prism Healthcare, added: “We are thrilled to welcome Charme as a new investor in Prism Healthcare and are confident they are the right partner, with the right skills and experience, to help us realise our ambitious growth objectives.

“I would like to thank Gary and the team at FRP Corporate Finance for their support on such a landmark deal – we’re excited to embark on a new chapter for Prism Healthcare, whilst continuing to support our customers and their clients in homecare, long term care and the paediatric market by making care easier.”